feed,title,long_url,short_url
MedRxiv,SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: genomic surveillance in Japan from September 2021 to March 2022,https://medrxiv.org/cgi/content/short/2022.04.05.22273483v1?rss=1,https://bit.ly/3j9QqK3
MedRxiv,Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults,https://medrxiv.org/cgi/content/short/2022.04.05.22273480v1?rss=1,https://bit.ly/3DO7azZ
MedRxiv,Unsuppressed HIV infection impairs T cell responses to SARS-CoV-2 infection and abrogates T cell cross-recognition,https://medrxiv.org/cgi/content/short/2022.04.05.22273453v1?rss=1,https://bit.ly/3Kb2bvz
MedRxiv,Multiplexed biosensor for point-of-care COVID-19 monitoring: CRISPR-powered unamplified RNA diagnostics and protein-based therapeutic drug management,https://medrxiv.org/cgi/content/short/2022.03.30.22271928v1?rss=1,https://bit.ly/3x54w7D
MedRxiv,Effect of Heat inactivation and bulk lysis on Real-Time Reverse Transcription PCR Detection of the SARS-COV-2: An Experimental Study,https://medrxiv.org/cgi/content/short/2022.04.04.22273334v1?rss=1,https://bit.ly/3NRgKXs
